Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 9;13(8):e17021.
doi: 10.7759/cureus.17021. eCollection 2021 Aug.

Kikuchi-Fujimoto Disease: A Rare Cause of Cervical Lymphadenopathy

Affiliations
Review

Kikuchi-Fujimoto Disease: A Rare Cause of Cervical Lymphadenopathy

Zubayer Ahmed et al. Cureus. .

Abstract

Kikuchi-Fujimoto disease (KFD) is a rare benign disease, clinically characterized by fever and tender cervical lymphadenopathy affecting the posterior cervical lymph nodes. This disease is usually accompanied by night sweats, rashes, and headaches. It generally affects young individuals, especially females, of Oriental-Asian origin. The etiology of KFD remains uncertain, but associations have been noted with viral diseases including Epstein-Barr virus (EBV), herpes simplex virus (HSV), and varicella-zoster virus (VZV), as well as autoimmune disorders including systemic lupus erythematosus (SLE) and Sjogren's syndrome. This review points out the etiology of KFD with cervical lymphadenopathy alongside its clinical presentation, histological highlights, lab investigations, complications, and treatment. Accurate diagnosis of this disease depends on lymph node excisional biopsy. Three histological patterns of KFD are recognized: proliferative, necrotizing, and xanthomatous. Distinction from lymphadenopathy-associated alternate disorders (e.g., SLE, malignancy, tuberculosis, or another infectious lymphadenitis) is essential to ensure appropriate therapy. This self-limited condition entails nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief with consideration of corticosteroids and hydroxychloroquine in severe cases.

Keywords: autoimmune diseases; immunohistochemistry; kikuchi-fujimoto disease; lymphadenopathy; viral infection.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow chart showing the treatment of Kikuchi-Fujimoto disease (KFD)
NSAIDs: Nonsteroidal anti-inflammatory drugs; SLE: Systemic lupus erythematosus; IL-1: Interleukin-1

References

    1. Kikuchi Fujimoto disease. Jamal AB. Clin Med Insights Arthritis Musculoskelet Disord. 2012;5:63–66. - PMC - PubMed
    1. The differential diagnosis of bilateral pleural effusion and multiple mediastinal lymphadenopathies includes Kikuchi-Fujimoto disease. Huang C. J Investig Med High Impact Case Rep. 2020;8:1–4. - PMC - PubMed
    1. Kikuchi-Fujimoto disease: a review. Perry AM, Choi SM. Arch Pathol Lab Med. 2018;142:1341–1346. - PubMed
    1. Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures. Xu S, Sun W, Liu J. BMC Oral Health. 2019;19:223. - PMC - PubMed
    1. The enigmatic Kikuchi-Fujimoto disease: a case report and review. Tariq H, Gaduputi V, Rafiq A, Shenoy R. Case Rep Hematol. 2014;2014:648136. - PMC - PubMed

LinkOut - more resources